lobbying_activities: 3801654

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3801654	ef160ad1-7d1a-40ec-b4ae-fa35eacb12ea	Q1	THE WASHINGTON TAX & PUBLIC POLICY GROUP	294930	REGENERON PHARMACEUTICALS, INC.	2026	first_quarter	TAX	Issues related to corporate and international taxation. Issues related to OECD Pillar 2 negotiations and agreements on the taxation of global income. Issues related to IRC sections 11, 951A, 250, and 174.		30000		0	0	2026-04-01T13:15:25-04:00